The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor

Area of Science:

• Cardiovascular Medicine
• Immunology
• Biochemistry

Background:

• Complement 1 (C1) inhibitor is recognized for its anti-inflammatory properties.
• Arterial stiffness, measured by brachial-ankle pulse wave velocity (baPWV), is a significant cardiovascular risk indicator.
• The relationship between C1 inhibitor levels and arterial stiffness requires further elucidation.

Purpose of the Study:

• To investigate the association between C1 inhibitor levels and arterial stiffness (baPWV).
• To determine if C1 inhibitor is an independent predictor of arterial stiffness.
• To explore the role of inflammation in the relationship between C1 inhibitor and arterial stiffness.

Main Methods:

• A cohort of 100 subjects was enrolled.
• Data collected included baPWV, demographics, medical history, BMI, and various blood markers.
• Pearson correlation and multiple regression analyses were employed to assess relationships.

Main Results:

• A significant positive correlation was observed between C1 inhibitor levels and baPWV (P<0.001).
• Multiple regression analysis identified C1 inhibitor as a significant predictor of baPWV, alongside age, gender, hypertension, and BMI.
• These findings were independent of other measured inflammatory markers.

Conclusions:

• C1 inhibitor is significantly associated with arterial stiffness.
• C1 inhibitor may serve as an independent predictor of arterial stiffness.
• The association suggests a potential role for C1 inhibitor in the inflammatory pathways contributing to arterial stiffness.